DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Wednesday reported a loss of $31.1 million in its first quarter.
On a per-share basis, the Durham, North Carolina-based company said it had a loss of 28 cents.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 28 cents per share.
The drugmaker posted revenue of $5.9 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $2.9 million.
BioCryst shares have fallen almost 5% since the beginning of the year. The stock has climbed 38% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX